Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival
Titel:
Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival
Auteur:
Venner, Christopher P. Lane, Thirusha Foard, Darren Rannigan, Lisa Gibbs, Simon D.J. Pinney, Jennifer H. Whelan, Carol J. Lachmann, Helen J. Gillmore, Julian D. Hawkins, Philip N. Wechalekar, Ashutosh D.